Comment on The FDA’s Overdue Crackdown on Misleading Pharmaceutical Advertisements by Someone Else

['Mia Editors', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright'] Comments for Mad In America 2025-09-22 13:22:19

From JAMA Network: “The US is one of only 2 countries worldwide that permits direct-to-consumer pharmaceutical advertising. Within a decade of this regulatory change, pharmaceutical advertising spending increased by nearly 800%, many creating a misleading impression. One analysis found that more than 1800 social media advertisements from 15 telehealth companies promoted prescription drugs without warnings or risks, including at least 800 advertisements promoting controlled substances. Drug advertisements on social media are often presented as entertainment, blurring the boundaries between editorial content, user-generated media, and pharmaceutical advertising. A 2024 review revealed that while 100% of pharmaceutical social media posts highlighted drug benefits, only 33% mentioned potential harms.